Seaport Therapeutics, Inc.
Statements
Cash Flow
Seaport Therapeutics, Inc. (SPTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -78 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| -30 | -78 | |
| 0.2 | 1.4 | |
| 15 | 6.9 | |
| 2.5 | -7.9 | |
| 0.1 | 0.4 | |
| – | -184 | |
| 339 | -0.9 | |
| 310 | -263 | |
| -30 | -78 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.